• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人CD4+CD25+调节性T细胞对低剂量环磷酰胺敏感:对免疫反应的影响。

Human CD4+CD25+ regulatory T cells are sensitive to low dose cyclophosphamide: implications for the immune response.

作者信息

Heylmann Daniel, Bauer Martina, Becker Huong, van Gool Stefaan, Bacher Nicole, Steinbrink Kerstin, Kaina Bernd

机构信息

Department of Toxicology, University Medical Center, Mainz, Germany.

Pediatric Neuro-Oncology, University Hospitals, Leuven, Belgium.

出版信息

PLoS One. 2013 Dec 23;8(12):e83384. doi: 10.1371/journal.pone.0083384. eCollection 2013.

DOI:10.1371/journal.pone.0083384
PMID:24376696
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3871695/
Abstract

Regulatory T cells (Treg) play a pivotal role in the immune system since they inhibit the T cell response. It is well known that cyclophosphamide applied at low dose is able to stimulate the immune response while high dose cyclophosphamide exerts inhibitory activity. Data obtained in mice indicate that cyclophosphamide provokes a reduction in the number of Treg and impairs their suppressive activity, resulting in immune stimulation. Here, we addressed the question of the sensitivity of human Treg to cyclophosphamide, comparing Treg with cytotoxic T cells (CTL) and T helper cells (Th). We show that Treg are more sensitive than CTL and Th to mafosfamide, which is an active derivative of cyclophosphamide, which does not need metabolic activation. The high sensitivity of Treg was due to the induction of apoptosis. Treg compared to CTL and Th were not more sensitive to the alkylating drugs temozolomide and nimustine and also not to mitomycin C, indicating a specific Treg response to mafosfamide. The high sensitivity of Treg to mafosfamide resulted not only in enhanced cell death, but also in impaired Treg function as demonstrated by a decline in the suppressor activity of Treg in a co-culture model with Th and Helios positive Treg. Treatment of Treg with mafosfamide gave rise to a high level of DNA crosslinks, which were not repaired to the same extent as observed in Th and CTL. Also, Treg showed a low level of γH2AX foci up to 6 h and a high level 24 h after treatment, indicating alterations in the DNA damage response. Overall, this is the first demonstration that human Treg are, in comparison with Th and CTL, hypersensitive to cyclophosphamide, which is presumably due to a DNA repair defect.

摘要

调节性T细胞(Treg)在免疫系统中发挥着关键作用,因为它们能抑制T细胞反应。众所周知,低剂量应用的环磷酰胺能够刺激免疫反应,而高剂量的环磷酰胺则具有抑制活性。在小鼠中获得的数据表明,环磷酰胺会导致Treg数量减少并损害其抑制活性,从而引发免疫刺激。在此,我们探讨了人类Treg对环磷酰胺的敏感性问题,将Treg与细胞毒性T细胞(CTL)和辅助性T细胞(Th)进行了比较。我们发现,Treg比CTL和Th对马法兰更敏感,马法兰是环磷酰胺的一种活性衍生物,无需代谢激活。Treg的高敏感性是由于细胞凋亡的诱导。与CTL和Th相比,Treg对烷化剂替莫唑胺和尼莫司汀以及丝裂霉素C并不更敏感,这表明Treg对马法兰有特异性反应。Treg对马法兰的高敏感性不仅导致细胞死亡增加,还损害了Treg的功能,这在与Th和Helios阳性Treg的共培养模型中Treg抑制活性的下降中得到了证明。用马法兰处理Treg会导致高水平的DNA交联,其修复程度不如在Th和CTL中观察到的那样。此外,Treg在处理后6小时内γH2AX焦点水平较低,24小时后水平较高,表明DNA损伤反应发生了改变。总体而言,这是首次证明与Th和CTL相比,人类Treg对环磷酰胺高度敏感,这可能是由于DNA修复缺陷所致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826d/3871695/2ee69824740b/pone.0083384.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826d/3871695/132fbb542a61/pone.0083384.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826d/3871695/f6ed3482cbae/pone.0083384.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826d/3871695/9f11b4b64c17/pone.0083384.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826d/3871695/c4c079d11747/pone.0083384.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826d/3871695/2df05031c70d/pone.0083384.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826d/3871695/f8ae20e841e0/pone.0083384.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826d/3871695/2ee69824740b/pone.0083384.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826d/3871695/132fbb542a61/pone.0083384.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826d/3871695/f6ed3482cbae/pone.0083384.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826d/3871695/9f11b4b64c17/pone.0083384.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826d/3871695/c4c079d11747/pone.0083384.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826d/3871695/2df05031c70d/pone.0083384.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826d/3871695/f8ae20e841e0/pone.0083384.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826d/3871695/2ee69824740b/pone.0083384.g007.jpg

相似文献

1
Human CD4+CD25+ regulatory T cells are sensitive to low dose cyclophosphamide: implications for the immune response.人CD4+CD25+调节性T细胞对低剂量环磷酰胺敏感:对免疫反应的影响。
PLoS One. 2013 Dec 23;8(12):e83384. doi: 10.1371/journal.pone.0083384. eCollection 2013.
2
Selective depletion of CD4+CD25+Foxp3+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels.低剂量环磷酰胺通过降低细胞内 ATP 水平来选择性耗竭 CD4+CD25+Foxp3+调节性 T 细胞。
Cancer Res. 2010 Jun 15;70(12):4850-8. doi: 10.1158/0008-5472.CAN-10-0283. Epub 2010 May 25.
3
Cyclophosphamide inhibits the generation and function of CD8(+) regulatory T cells.环磷酰胺抑制 CD8(+)调节性 T 细胞的生成和功能。
Hum Immunol. 2012 Mar;73(3):207-13. doi: 10.1016/j.humimm.2011.12.020. Epub 2012 Jan 14.
4
Corticosteroids do not reverse the inhibitory effect of cyclosporine on regulatory T-cell activity in contrast to mycophenolate mofetil.与霉酚酸酯不同,皮质类固醇不能逆转环孢素对调节性T细胞活性的抑制作用。
Transplant Proc. 2012 Nov;44(9):2834-9. doi: 10.1016/j.transproceed.2012.09.091.
5
The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.免疫抑制药物雷帕霉素对小鼠调节性CD4+CD25+Foxp3+T细胞的影响。
Transpl Immunol. 2007 Apr;17(3):153-61. doi: 10.1016/j.trim.2007.01.002. Epub 2007 Jan 24.
6
Inhibitory effects of cyclosporine on human regulatory T cells in vitro.环孢素在体外对人调节性T细胞的抑制作用。
Transplant Proc. 2009 Oct;41(8):3371-4. doi: 10.1016/j.transproceed.2009.08.043.
7
Critical stoichiometric ratio of CD4(+)  CD25(+)  FoxP3(+) regulatory T cells and CD4(+)  CD25(-) responder T cells influence immunosuppression in patients with B-cell acute lymphoblastic leukaemia.B 细胞急性淋巴细胞白血病患者中 CD4(+)CD25(+)FoxP3(+)调节性 T 细胞与 CD4(+)CD25(-)应答性 T 细胞的临界化学计量比影响免疫抑制。
Immunology. 2014 May;142(1):124-39. doi: 10.1111/imm.12237.
8
Cyclophosphamide and abrogation of tumor-induced suppressor T cell activity.环磷酰胺与肿瘤诱导的抑制性T细胞活性的消除
Cancer Immunol Immunother. 1990;31(2):121-7. doi: 10.1007/BF01742376.
9
Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.雷帕霉素与环孢菌素 A 不同,可增强体外诱导的 CD4+CD25+Treg 的抑制功能。
Nephrol Dial Transplant. 2010 Mar;25(3):710-7. doi: 10.1093/ndt/gfp586. Epub 2009 Nov 9.
10
Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.体外供体同种异体抗原刺激的CD4(+)CD25(+)调节性T细胞的过继性输血可改善DA到Lewis大鼠肝移植的排斥反应。
Surgery. 2007 Jul;142(1):67-73. doi: 10.1016/j.surg.2007.02.014.

引用本文的文献

1
Adoptive cell therapy for cancer: combination strategies and biomarkers.癌症的过继性细胞疗法:联合策略与生物标志物
Front Immunol. 2025 Aug 1;16:1603792. doi: 10.3389/fimmu.2025.1603792. eCollection 2025.
2
The Role of the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma: Recent Advancements and Emerging Therapeutic Strategies.肿瘤微环境在胰腺导管腺癌中的作用:最新进展与新兴治疗策略
Cancers (Basel). 2025 May 8;17(10):1599. doi: 10.3390/cancers17101599.
3
The Complexity of Malignant Glioma Treatment.恶性胶质瘤治疗的复杂性

本文引用的文献

1
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival.单次剂量环磷酰胺后,IMA901 癌症疫苗的多肽免疫反应与患者更长的生存时间相关。
Nat Med. 2012 Aug;18(8):1254-61. doi: 10.1038/nm.2883. Epub 2012 Jul 29.
2
Human monocytes undergo excessive apoptosis following temozolomide activating the ATM/ATR pathway while dendritic cells and macrophages are resistant.替莫唑胺激活 ATM/ATR 通路后,人类单核细胞过度凋亡,而树突状细胞和巨噬细胞则具有抗性。
PLoS One. 2012;7(6):e39956. doi: 10.1371/journal.pone.0039956. Epub 2012 Jun 29.
3
Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis.
Cancers (Basel). 2025 Mar 4;17(5):879. doi: 10.3390/cancers17050879.
4
Breaking the shield of solid tumors: a combined approach for enhanced efficacy of CAR-T cells.突破实体瘤的屏障:增强 CAR-T 细胞疗效的联合方法。
Cancer Immunol Immunother. 2024 Nov 2;74(1):3. doi: 10.1007/s00262-024-03817-z.
5
Oncolytic Viruses as Reliable Adjuvants in CAR-T Cell Therapy for Solid Tumors.溶瘤病毒在 CAR-T 细胞治疗实体瘤中的可靠佐剂作用。
Int J Mol Sci. 2024 Oct 16;25(20):11127. doi: 10.3390/ijms252011127.
6
Revolutionizing Cancer Treatment: Recent Advances in Immunotherapy.变革癌症治疗:免疫疗法的最新进展
Biomedicines. 2024 Sep 23;12(9):2158. doi: 10.3390/biomedicines12092158.
7
Towards targeting the breast cancer immune microenvironment.针对乳腺癌免疫微环境。
Nat Rev Cancer. 2024 Aug;24(8):554-577. doi: 10.1038/s41568-024-00714-6. Epub 2024 Jul 5.
8
Making a Monkey out of Human Immunodeficiency Virus/Simian Immunodeficiency Virus Pathogenesis: Immune Cell Depletion Experiments as a Tool to Understand the Immune Correlates of Protection and Pathogenicity in HIV Infection.将人类免疫缺陷病毒/猴免疫缺陷病毒发病机制搞得一团糟:免疫细胞耗竭实验作为一种工具,用于理解 HIV 感染中的免疫保护相关性和致病性的免疫相关性。
Viruses. 2024 Jun 17;16(6):972. doi: 10.3390/v16060972.
9
IL3-Driven T Cell-Basophil Crosstalk Enhances Antitumor Immunity.IL3 驱动的 T 细胞-嗜碱性粒细胞串扰增强抗肿瘤免疫。
Cancer Immunol Res. 2024 Jul 2;12(7):822-839. doi: 10.1158/2326-6066.CIR-23-0851.
10
The Macrophage Activator GcMAF-RF Enhances the Antitumor Effect of Karanahan Technology through Induction of M2-M1 Macrophage Reprogramming.巨噬细胞激活因子 GcMAF-RF 通过诱导 M2-M1 巨噬细胞重编程增强了 Karanahan 技术的抗肿瘤作用。
J Immunol Res. 2024 Feb 29;2024:7484490. doi: 10.1155/2024/7484490. eCollection 2024.
狼疮和小血管血管炎继发肾小球肾炎患者的环磷酰胺和 4-羟基环磷酰胺药代动力学。
Br J Clin Pharmacol. 2012 Sep;74(3):445-55. doi: 10.1111/j.1365-2125.2012.04223.x.
4
DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis.DNA 损伤诱导的细胞死亡:从特定的 DNA 损伤到 DNA 损伤反应和细胞凋亡。
Cancer Lett. 2013 May 28;332(2):237-48. doi: 10.1016/j.canlet.2012.01.007. Epub 2012 Jan 17.
5
Human monocytes are severely impaired in base and DNA double-strand break repair that renders them vulnerable to oxidative stress.人类单核细胞在碱基和 DNA 双链断裂修复方面严重受损,这使它们容易受到氧化应激的影响。
Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21105-10. doi: 10.1073/pnas.1111919109. Epub 2011 Dec 12.
6
Immune recovery after cyclophosphamide treatment in multiple myeloma: implication for maintenance immunotherapy.多发性骨髓瘤患者环磷酰胺治疗后的免疫恢复:对维持免疫治疗的启示
Bone Marrow Res. 2011;2011:269519. doi: 10.1155/2011/269519. Epub 2011 Apr 6.
7
Helios expression is a marker of T cell activation and proliferation.Helios 表达是 T 细胞活化和增殖的标志物。
PLoS One. 2011;6(8):e24226. doi: 10.1371/journal.pone.0024226. Epub 2011 Aug 30.
8
Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome.转移性乳腺癌患者的节拍式环磷酰胺治疗:免疫效应和临床结局。
Cancer Immunol Immunother. 2012 Mar;61(3):353-62. doi: 10.1007/s00262-011-1106-3. Epub 2011 Sep 14.
9
Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumors.胸腺来源的调节性 T 细胞而非肿瘤诱导的调节性 T 细胞在脑肿瘤中占优势。
Neuro Oncol. 2011 Dec;13(12):1308-23. doi: 10.1093/neuonc/nor134. Epub 2011 Sep 8.
10
Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression.顺铂敏感的睾丸肿瘤细胞系存在链间交联修复缺陷和 ERCC1-XPF 表达降低。
Mol Cancer. 2010 Sep 16;9:248. doi: 10.1186/1476-4598-9-248.